Abstract:The human telomeric DNA, which consists of tandem repeat sequences of d(TTAGGG)n, plays an important role in cancers and cell aging. Previous studies in human cancer cells have demonstrated DNA G-quadruplex (G4) structure formation in telomeres. G-quadruplexes are four-stranded structures formed in guanine-rich sequences that are held together by guanine-guanine Hoogsteen hydrogen bonding, and G-quadruplex stabilization by small molecules induces tumor cell senescence and apoptosis by repressing telomerase activity and the DNA damage response pathway. Additionally, telomeric-overhang DNA can form biologically relevant higher-order DNA structures containing consecutive G-quadruplexes which provides additional binding sites for small molecules. Thus, telomeric DNA G-quadruplexes have attracted increasing interest as potential drug targets for cancer therapy. Here, we found that a novel platinum (II)-based tripod (Pt-tripod) specifically recognizes the hybrid-1 human telomeric G4, which is formed in the physiologically relevant K+ solution. Pt-tripod strongly represses telomerase activity and exhibits DNA-targeted photodynamic therapy anticancer activity. Using NMR, we show that Pt-tripod binds the hybrid-1 human telomeric G4 over other G-quadruplex structures and dsDNA. We determined solution structures of the 1:1 and the dimeric 4:2 Pt-tripod-hybrid-1 telomeric G4 complexes by NMR. Our 1:1 complex structure shows preferential binding of the Pt-tripod to the 5′-end of hybrid-1 telomeric G4. At higher ligand ratio, Pt-tripod binds to the 3′-end of the hybid-1 G4 and induces an unprecedented dimeric 4:2 structure interlocked by a non-canonical A:A pair at the 3′-end. The specific binding of the Pt-tripod with the hybrid-1 G4 is achieved by unique interaction modes including the π-π stacking, hydrogen bonding, and electrostatic interactions with the loop and flanking segments. The non-planar tertiary amine conformation and three properly sized cationic platinum arms are critical for the specific and strong binding. Our structures provide significant insights into understanding the dynamic binding of small molecules with G-quadruplexes, and a structural basis for future rational anticancer drug design of non-planar small molecules targeting the human telomeric G4. Our studies also provide a potential handle to study the specific protein interactions and biological functions of hybrid-1 human telomeric G4. Citation Format: Wenting Liu, Clement Lin, Zong-wan Mao, Danzhou Yang. Recognition of the hybrid-1 human telomeric G-quadruplex by a platinum(II)-based compound [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2752.

Specific Targeting of Telomeric Multimeric G-quadruplexes by a New Triaryl-Substituted Imidazole.

G-Quadruplex binding enantiomers show chiral selective interactions with human telomere

Recent Advances in the Development of Ligands Specifically Targeting Telomeric Multimeric G-quadruplexes.

Discovery of Novel Schizocommunin Derivatives As Telomeric G-Quadruplex Ligands That Trigger Telomere Dysfunction and the Deoxyribonucleic Acid (DNA) Damage Response

Molecular Recognition of the Hybrid-Type G-Quadruplexes in Human Telomeres

Dimeric Aryl-Substituted Imidazoles May Inhibit ALT Cancer by Targeting the Multimeric G-quadruplex in Telomere

Molecular Recognition and Imaging of Human Telomeric G-Quadruplex DNA in Live Cells: A Systematic Advancement of Thiazole Orange Scaffold To Enhance Binding Specificity and Inhibition of Gene Expression

Chemical targeting of G-quadruplexes in telomeres and beyond for molecular cancer therapeutics

Novel quinoxaline analogs as telomeric G-quadruplex ligands exert antitumor effects related to enhanced immunomodulation

Specific Recognition And Stabilization Of Monomeric And Multimeric G-Quadruplexes By Cationic Porphyrin Tmpipeopp Under Molecular Crowding Conditions

Benzimidazole-based small molecules as anticancer agents targeting telomeric G-quadruplex and inhibiting telomerase enzyme

Research Progress of Targeting G-quadruplex Anticancer Agents

Rational design of small-molecules to recognize G-quadruplexes of c-MYC promoter and telomere and the evaluation of their in vivo antitumor activity against breast cancer

NIR imaging human telomeric dimeric G-quadruplexes by malachite green dimers and their antitumor activity

Abstract 2752: Recognition of the Hybrid-1 Human Telomeric G-quadruplex by a Platinum(ii)-Based Compound

Synthesis and Evaluation of Quindoline Derivatives As G-quadruplex Inducing and Stabilizing Ligands and Potential Inhibitors of Telomerase.

Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands

Disubstituted 2-Phenyl-benzopyranopyrimidine Derivatives As A New Type of Highly Selective Ligands for Telomeric G-Quadruplex Dna

Targeting Human Telomeric G-Quadruplex Dna And Inhibition Of Telomerase Activity With [(Dmb)(2)Ru(Obip)Ru(Dmb)(2)](4+)

G-quadruplex DNA selective targeting for anticancer therapy: a computational study of a novel PtII monofunctional complex activated by adaptive binding.

Pharmacophore-based discovery of triaryl-substituted imidazole as new telomeric G-quadruplex ligand.